Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
AIDS Behav. 2021 Apr;25(4):1129-1143. doi: 10.1007/s10461-020-03063-1. Epub 2020 Oct 30.
We conducted a novel pilot randomized controlled trial of the Treatment Ambassador Program (TAP), an 8-session, peer-based, behavioral intervention for people with HIV (PWH) in South Africa not on antiretroviral therapy (ART). PWH (43 intervention, 41 controls) completed baseline, 3- and 6-month assessments. TAP was highly feasible (90% completion), with peer counselors demonstrating good intervention fidelity. Post-intervention interviews showed high acceptability of TAP and counselors, who supported autonomy, assisted with clinical navigation, and provided psychosocial support. Intention-to-treat analyses indicated increased ART initiation by 3 months in the intervention vs. control arm (12.2% [5/41] vs. 2.3% [1/43], Fisher exact p-value = 0.105; Cohen's h = 0.41). Among those previously on ART (off for > 6 months), 33.3% initiated ART by 3 months in the intervention vs. 14.3% in the control arm (Cohen's h = 0.45). Results suggest that TAP was highly acceptable and feasible among PWH not on ART.
我们开展了一项新的试点随机对照试验,研究了治疗大使计划(TAP),这是一种针对南非未接受抗逆转录病毒治疗(ART)的艾滋病毒感染者(PWH)的 8 节基于同伴的行为干预措施。PWH(43 名干预组,41 名对照组)完成了基线、3 个月和 6 个月的评估。TAP 具有很高的可行性(完成率为 90%),同伴顾问表现出良好的干预一致性。干预后的访谈表明,TAP 和顾问的接受度很高,他们支持自主性,协助临床导航,并提供心理社会支持。意向治疗分析表明,干预组在 3 个月时开始接受 ART 的比例高于对照组(12.2%[5/41]比 2.3%[1/43],Fisher 精确检验 p 值=0.105;Cohen's h=0.41)。在那些之前接受过 ART(停药超过 6 个月)的人中,干预组有 33.3%在 3 个月时开始接受 ART,而对照组为 14.3%(Cohen's h=0.45)。结果表明,TAP 在未接受 ART 的 PWH 中具有很高的可接受性和可行性。